December 26, 2014 6:51 AM ET

Pharmaceuticals

Company Overview of ViroPharma Inc.

Executive Profile

Marc S. Collett Ph.D.

Member of Scientific Advisory Board, AlphaVax, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
62--

Background

Dr. Marc S. Collett, Ph.D. co-founded and serves as Vice President and Chief Scientific Officer of Profectus Biosciences, Inc. Dr. Collett founded and serves as President of ViroDefense Inc. Dr. Collett also co-founded ViroPharma Inc. and served as its Vice President, Discovery Research since December 1994. He served as Vice President, Research of Acambis. From 1993 until 1994, Dr. Collett served as Senior Director, Viral Therapeutics at PathoGenesis Corporation, a biotechnology ...

Corporate Headquarters

730 Stockton Drive
Exton, Pennsylvania 19341

United States

Phone: 610-458-7300
Fax: 610-458-7380

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
University of Michigan
BS
University of Michigan

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ViroPharma Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.